Business Wire

Rockwell Automation Demonstrates Commitment to Houston

Del

Weeks after the devastation from Hurricane Harvey and Irma, leaders at Rockwell Automation are confidently moving forward with plans to host the annual Automation Fair event in Houston. “Our hearts go out to the greater Houston community and all who have been affected by the recent hurricanes,” said Blake Moret, president and CEO, Rockwell Automation. “We have made a commitment to the city of Houston, and want our event to be one of the ways we help the community and the region recover.”

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171006005094/en/

Blake Moret, President and CEO, Rockwell Automation, will share his vision and insight on the automa ...

Blake Moret, President and CEO, Rockwell Automation, will share his vision and insight on the automation trends and technologies helping to drive performance and improve industrial productivity at the Automation Perspectives global media forum, scheduled for Nov. 14 at the Hilton Americas-Houston. (Photo: Business Wire)

Impressed by the recovery already occurring and working closely with Visit Houston, the Greater Houston Convention and Visitors Bureau, and the George R. Brown Convention Center, Rockwell Automation has plans in place to ensure the success of this year’s event, which attracts thousands of attendees each year.

Registration is now open for the 2017 Automation Fair event, hosted by Rockwell Automation and members of its global PartnerNetwork program. The event offers manufacturers and producers from around the world the opportunity to see the latest products, services and solutions to help enable a Connected Enterprise.

“The focus for this year’s event will be helping companies learn how to achieve measurable business results by integrating control and information across operations to enable better collaboration, faster problem-solving, and increased productivity,” stated Moret. “As a company, we are passionate about helping industrial companies and their people be more productive.”

Automation Fair Event

More than 140 exhibits showcasing the latest product innovations for industrial manufacturing and production from Rockwell Automation and its PartnerNetwork members will be on display Nov. 15 and 16. Across the show floor, attendees can see a wealth of product demonstrations and interact with industry experts. In addition, attendees can register for 19 hands-on, technology-focused labs and participate in over 90 technical sessions. They can also learn best practices from customers and industry leaders in nine forums including chemical; engineering, procurement and construction; food and beverage; machine and equipment builders; oil and gas; power and energy management; pulp and paper; water wastewater; and diversity and inclusion in manufacturing.

Process Solutions User Group (PSUG)

In addition, on Nov. 13 and 14, PSUG will bring together hundreds of operations, IT and engineering professionals from a variety of different industries to share best practices and learn about new process automation technologies aimed at improving operational performance. The event will feature approximately 25 technical sessions, 10 hands-on labs, and more than 25 presentations by Rockwell Automation customers. The event will also include a series of open-forum panel discussions.

Automation Perspectives Global Media Event

On Nov. 14, the annual Automation Perspectives global media forum will welcome media representatives and industry analysts to learn about global manufacturing and production challenges, and the automation trends and technologies helping to drive performance and improve industrial productivity. Executive leadership and industry experts will share their strategies for managing the opportunities and challenges of digitization, and the partnerships and programs aimed at developing a highly skilled workforce to meet the needs of advanced manufacturing.

Registration for the 2017 Automation Fair event, PSUG and the Automation Perspectives global media forum is now open.

About the Rockwell Automation PartnerNetwork Program

The Rockwell Automation PartnerNetwork program offers global manufacturers access to a collaborative network of companies mutually focused on developing, implementing and supporting best-in-breed solutions to achieve plant-wide optimization, improve machine performance and meet sustainability objectives.

About Rockwell Automation

Rockwell Automation Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and information, makes its customers more productive and the world more sustainable. Headquartered in Milwaukee, Wis., Rockwell Automation employs approximately 22,000 people serving customers in more than 80 countries.

Automation Fair, LISTEN. THINK. SOLVE. and PartnerNetwork are trademarks of Rockwell Automation Inc.

Contact information

Rockwell Automation
Kristen Crump
414.544.2076
klcrump@ra.rockwell.com
or
Padilla
Beatrice Zvosec
612.455.1914
beatrice.zvosec@padillaco.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha